Abstract
Psoriasis is a common inflammatory disease affecting 2% of the population. People who have severe psoriasis (requiring a systemic therapy) have a marked increase in cardiovascular disease. This could be due to an increased prevalence of traditional cardiovascular risk factors in people with psoriasis, the effect of chronic inflammation or a combination of both factors. Patients with severe disease should be risk assessed for cardiovascular disease and co-morbidities actively managed.
| Original language | English |
|---|---|
| Pages (from-to) | 30-33 |
| Number of pages | 4 |
| Journal | Heart and Metabolism |
| Issue number | 60 |
| Publication status | Published - Sept 2013 |
Keywords
- Anti-TNF therapy
- Cardiovascular disease
- Inflammation
- Psoriasis
- Skin disease
